Relapsed and/or Refractory Diffuse Large B-cell Lymphoma

Also known as: Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11891Fimepinostat1Completed1
DB00073Rituximab1Completed1
DB11581Venetoclax1Completed1